S-63845
CAS No. 1799633-27-4
S-63845 ( S 63845;S63845 )
Catalog No. M12723 CAS No. 1799633-27-4
S-63845 (S63845)is a highly potent, selective Mcl-1 inhibitor with Kd of 0.19 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 133 | Get Quote |
|
10MG | 222 | Get Quote |
|
25MG | 399 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameS-63845
-
NoteResearch use only, not for human use.
-
Brief DescriptionS-63845 (S63845)is a highly potent, selective Mcl-1 inhibitor with Kd of 0.19 nM.
-
DescriptionS-63845 (S63845)is a highly potent, selective Mcl-1 inhibitor with Kd of 0.19 nM, with no appreciable binding affinity to BCL-2 or BCL-XL (Ki>10 uM); binds to the BH3-binding groove of Mcl-1, potently kills MCL1-dependent cancer cells, including multiple myeloma (IC50<0.1 uM), leukaemia and lymphoma cells, by activating the BAX/BAK-dependent mitochondrial apoptotic pathway; is well tolerated and shopws high effectivity against mouse cancer models.Blood Cancer Preclinical
-
SynonymsS 63845;S63845
-
PathwayAngiogenesis
-
TargetBcl-2
-
RecptorBcl-2
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number1799633-27-4
-
Formula Weight829.26
-
Molecular FormulaC39H37ClF4N6O6S
-
Purity>98% (HPLC)
-
SolubilityDMSO
-
SMILESO=C(O)[C@@H](CC1=C(OCC2=CC=NN2CC(F)(F)F)C=CC=C1)OC3=C4C(SC(C5=CC=C(F)O5)=[C@@]4[C@@]6=C(C)C(Cl)=C(OCCN7CCN(C)CC7)C=C6)=NC=N3
-
Chemical NameDispiro[cyclohexane-1,2'-[2H]indene-1'(3'H),2''-[2H]imidazol]-4''-amine, 4-methoxy-5''-methyl-6'-[5-(1-propyn-1-yl)-3-pyridinyl]-, (1α,1'R,4β)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kotschy A, et al. Nature. 2016 Oct 27;538(7626):477-482.
2. Merino D, et al. Sci Transl Med. 2017 Aug 2;9(401). pii: eaam7049.
3. Letai A. Cancer Cell. 2016 Dec 12;30(6):834-835.
2. Merino D, et al. Sci Transl Med. 2017 Aug 2;9(401). pii: eaam7049.
3. Letai A. Cancer Cell. 2016 Dec 12;30(6):834-835.
molnova catalog
related products
-
Isoverticine
Isoverticine exhibits significant antitussive, expectorant and anti-inflammatory activities, it also displays significant cytotoxicity.
-
Bax activator compou...
A specific, small molecule Bax agonist that promotes Bax-dependent but not Bak-dependent apoptosis.
-
BRD1991
BRD1991 is a small molecule that selectively disrupt Beclin 1/Bcl-2 binding as compared to Bax/Bcl-2 and Bim/Bcl-2 binding and induces autophagic flux at concentrations with minimal cytotoxicity.